Sample sent on : July 7, 2003 Report deadline: July 14, 2003
Total screening unit:11 Total reports returned:11
Sample No. |
A1 |
A2 |
A3 |
B1 | B2 | C1 | C2 | C3 | C4 | C5 | D1 | G6PD activity* |
1 |
+ |
0.3(+) |
1.3(+) |
0.1(+) |
+ |
1.2(+) |
+ |
+ |
0.6(+) |
0.55(+) |
0.2(+) |
1.8(+) |
2 |
- |
1.8(+) |
5.7(+) |
2.1 (-) |
- |
1.8 (-) |
- |
- |
1.7(+) |
3.16 (-) |
1.2 (-) |
4.6 |
3 |
- |
1.9(+) |
6.4 (-) |
1.7 (-) |
- |
1.9 (-) |
- |
- |
1.9(+) |
2.44 (-) |
1.3 (-) |
4.6 |
4 |
- |
2.0(+) |
6.3 (-) |
1.6 (-) |
- |
2.5(-) |
- |
- |
1.6(+) |
3.07 (-) |
1.4 (-) |
4.6 |
5 |
+ |
0.4(+) |
0.7(+) |
0.1(+) |
+ |
0.6(+) |
+ |
+ |
0.5(+) |
0.67 (+) |
0.2(+) |
1.8(+) |
6 |
- |
1.8(+) |
5.4(+) |
2.0 (-) |
- |
1.9 (-) |
- |
- |
2.6(-) |
3.37 (-) |
1.4 (-) |
4.6 |
7 |
- |
1.8(+) |
6.7 (-) |
1.9 (-) |
- |
1.7 (-) |
- |
- |
2.6(-) |
3.18 (-) |
1.3 (-) |
4.6 |
8 |
+ |
0.4(+) |
1.6(+) |
0.1(+) |
+ |
0.2(+) |
+ |
+ |
0.7(+) |
0.63(+) |
0.2(+) |
1.8(+) |
9 |
- |
1.9(+) |
6.1(-) |
1.7 (-) |
- |
1.7 (-) |
- |
- |
1.7(+) |
3.48 (-) |
1.3 (-) |
4.6 |
10 |
- |
1.9(+) |
6.1(-) |
1.7(-) |
- |
2.4(-) |
- |
- |
4.8(-) |
2.13(-) |
1.2(-) |
4.6 |
* G6PD:U/g Hb, determined at Clin. Biochem. Res. Lab, VGH-Taipei
** The positive result assigned by the participants are indicated by red color in the table.
Reagent Kit |
Screening Units |
Roche | A1, C2 |
PE (ND-1000) | A2, B1, C1, D1 |
Sigma Diagnostic 345B | A3 |
Gamma (G6PD-2000) | C4 |
R & D Diagnostics (OSMMR2000-D) | C5 |
Laboratory prepared | B2, C3 |
Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :
updated : 20 Dec, 2004